Spots Global Cancer Trial Database for A Phase I Study of QL1604 for Advanced Solid Tumors
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Phase I Study of QL1604 for Advanced Solid Tumors
Official Title: A Phase I Clinical Study to Evaluate Safety、 Tolerability, and Pharmacokinetics of QL1604 for the Treatment of Advanced Solid Tumors - A Phase Ic Preliminary Efficacy Expansion Study
Study ID: NCT05801094
Conditions
Interventions
Study Description
Brief Summary: In this study, patients with advance solid tumors will be treated with QL1604 monotherapy.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
The First Affliated Hospital of Nanchang University, Nanchang, , China
Fudan University Shanghai Cancer Center, Shanghai, , China
Contact Details
Name: Weijian Guo, PhD
Affiliation: Fudan University
Role: STUDY_CHAIR
Name: Jianping Xiong, PhD
Affiliation: The First Affliated Hospital of Nanchang University
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
